Día Mundial de la Trombosis

Movimiento global del Día Mundial de la Trombosis

Recursos para pacientes

Centros para el Control y la Prevención de Enfermedades (CDC) EE. UU.
Los Centros para el Control y la Prevención de Enfermedades (CDC, por sus siglas en inglés) se dedican a reducir la carga de morbilidad significativa de TEV y han establecido TEV asociada a los hospitales como una prioridad en materia de seguridad del paciente. Han realizado diversas actividades para generar conciencia sobre TVP y EP y han creado programas de vigilancia piloto para mejorar la supervisión hospitalaria de cada afección. Se han elaborado varios recursos educativos para el público, incluso una serie de seminarios web sobre trastornos de coagulación, un panel de presentación de diapositivas sobre TVP, una hoja de datos sobre cómo prevenir esta afección y una nueva campaña de salud del Centro de Hemostasia y Trombosis Duke sobre los riesgos de TVP en las mujeres.

Para obtener más información, visite http://www.cdc.gov/ncbddd/dvt/index.html.

National Blood Clot Alliance (NBCA) EE. UU.
La National Blood Clot Alliance (NBCA) es una organización de salud voluntaria y sin fines de lucro dedicada a promover la prevención, el diagnóstico precoz y el tratamiento adecuado de coágulos de sangre potencialmente mortales, como la trombosis venosa profunda, la embolia pulmonar y el ictus provocado por coágulos. La NBCA trabaja en nombre de personas que pueden padecer coágulos de sangre, incluyendo, entre otros, personas con trastornos de coagulación, fibrilación auricular, cáncer, traumatismos y riesgos relacionados con cirugías, inmovilidad prolongada, partos y anticoncepción. La organización cumple con su misión a través de programas que generan sensibilización pública, informan a pacientes y profesionales de atención médica y promueven políticas de apoyo en los sectores público y privado.

Para obtener más información, visite www.stoptheclot.org. Los pacientes pueden obtener más información sobre coágulos aquí: https://www.stoptheclot.org/learn_more/about-clots.htm.

Thrombosis UK (Reino Unido)
Dedicada a generar conciencia sobre la trombosis en el Reino Unido, Thrombosis UK ofrece diversos recursos para pacientes y oportunidades de participación. Más información aquí: www.thrombosisuk.org.

Recursos para profesionales de atención médica

Referencias para los modelos y las pautas de evaluación de riesgos de TEV

  • Barbar, S., Noventa, F., Rossetto, V., Ferrari, A., Brandolin, B., et al. A Risk Assessment Model for The Identification of Hospitalized Medical Patients at Risk for Venous Thromboembolism: The Padua Prediction Score. J Thromb Haemost 2010; 8: 2450–7.
  • Catterick, D., Hunt, B. Impact of the National Venous Thromboembolism Risk Assessment Tool in Secondary Care in England. Retrospective Population-Based Database Study. Blood Coagul Fibrinolysis, 2014 Sept; 25(6):571-576.
  • Lester, W., Freemantle, N., Begaj, I., Wood, J., Pagano, D. Fatal Venous Thromboembolism Associated with Hospital Admission: A Cohort Study to Assess the Impact of a National Risk Assessment Target. Heart, 2013. Dec; 99(23):1734-9.
  • Mahan, C.E., Liu, Y., Turpie, A.G., Vu, J.T., ,Heddle, N., et al. External Validation of a Risk Assessment Model for Venous Thromboembolism in the Hospitalised Acutely-ill Medical Patient (VTE-VALOURR). Journal of Thrombosis and Haemostasis, 2014; 112 (4):692.
  • NHS National Patient Safety Agency, Feb 2011. How to Guide: Venous Thromboembolism Risk Assessment.
  • NICE Implementation Collaborative Consensus, 2014. Supporting Local Implementation of NICE Guidance on Use of the Novel (non-Vitamin K Antagonist) Oral Anticoagulants in Non-Valvular Atrial Fibrillation.
  • Patient Centered Outcomes Resesarch Institute (PCORI), 2014. Improving Patient-Nurse Communication to Prevent a Life-Threatening Complication. Available from: www.pcori.org/research-in-action/improving-patient-nurse-communication-prevent-life-threatening-complication
  • Rosenberg, D., Eichorn, A., Alarcon M., McCullagh, L., McGinn, T., Spyropoulos, A.C. External Validation of the Risk Assessment Model of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) for Medical Patients in Tertiary Health System. Journal of American Heart Association, 2014;3:e001152.
  • Squizzato, A., Agena, W. A new Era for Venous Thromboembolism Prevention in Medical Inpatients. Journal of Thrombosis and Haemostasis, 2014; 112:692-699.
  • Stroud, W., Whitworth, J.M., Miklic, M., Schneider, K.E., Finan, M.A., et al. Validation of a Venous Thromboembolism Risk Assessment Model in Gynecologic Oncology. Gynecologic Oncology, 2014 Jan; 134(1):160-163.
  • Thrombosis Canada, 2015. Thromboprophylaxis: Hospitalized Medical Patients.
  • Thrombosis Canada, 2015. Thromboprophylaxis: For Non-Orthopedic Surgery.
  • Zhou, H., Wang, L., Tang, Y., Yang, J., Wang, B., et al. Validation of a Venous Thromboembolism Risk Assessment Model in Hospitalized Chinese Patients: A Case-Control Study. Journal of Atherosclerosis and Thrombosis, 2014; 21:261-272.
  • Zhou, H., Peng, L., Yan, Y., Yi, Q., Tang, Y., et al. Validation of the Caprini Risk Assessment Model in Chinese Hospitalized Patients with Venous Thromboembolism. Thrombosis Research, 2012; 130(5):735-740.

Referencias generales sobre TEV

  • Armstrong Institute for Patient Safety and Quality. "Preventing Venous Thromboembolism." Available from: www.hopkinsmedicine.org/armstrong_institute/improvement_projects/VTE/index.html.
  • Beckman, M. G., Hooper, W. C., Critchley, S. E., & Ortel, T. L. (2010). Venous thromboembolism. American Journal of Preventive Medicine, 38(4), S495–S501.
  • Centers for Disease Control and Prevention. Data & Statistics. (n.d.). Retrieved February 28, 2014, from http://www.cdc.gov/ncbddd/dvt/data.html.
  • Cohen, A. T., Agnelli, G., Anderson, F. A., Arcelus, J. I., Bergqvist, D., Brecht, J. G., et al. VTW Assessment Group in Europe (2007). Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Journal of Thrombosis and Haemostasis, 98(4), 756–764.
  • De Pasquale, Sue. (2015). Trailblazing Trend. Johns Hopkins Nursing. Retrieved from: http://magazine.nursing.jhu.edu/wp-content/uploads/2015/07/Johns_Hopkins_Nursing_Summer_2015.pdf.
  • Engbers, M. J., van Hylckama Vlieg, A., & Rosendaal, F. R. (2010). Venous thrombosis in the elderly: incidence, risk factors and risk groups. Journal of Thrombosis and Haemostasis, 8(10), 2105–2012.
  • Falck-Yitter, Y., Francis C. W., Johanson, N. A., Curley, C., Dahl, O. E., Schulman, S., et al. American College of Chest Physicians. (2012). Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-based Clinical Practice Guidelines. Chest, 141(2 Suppl), e278S–325S.
  • Gould, M. K., Garcia, D. A., Wren, S. M., Karanicolas, P. J., Arcelus, J. I., Heit, J. A., . . . American College of Chest Physicians. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-based Clinical Practice Guidelines. Chest, 141(2 Suppl), e227S–277S.
  • Heit, J. A., Cohen, A. T., & Anderson, F. A. (2005). Estimated Annual Number of Incident and Recurrent, Non-Fatal and Fatal Venous Thromboembolism (VTE) Events in the US. Blood (ASH Annual Meeting Abstracts), 106, abstract 910.
  • Heit, J. A. (2008). The epidemiology of venous thromboembolism in the community. Arteriosclerosis, Thrombosis, and Vascular Biology, 28(3), 370–372.
  • Hunt, B. J. (2008). Awareness and Politics of Venous Thromboembolism in the United Kingdom. Arteriosclerosis, Thrombosis, and Vascular Biology, 28(3), 398–399.
  • Jha, A. K., Larizgoitia I., Audera-Lopez C., Prasopa-Plaizier N., Waters, H., & Bates D. W. (2013). The global burden of unsafe medical care: analytic modelling of observational studies. BMJ Quality & Safety, 22(10), 809–815.
  • Kahn, S., Lim, W., Dunn, A. S., Cushman, M., Dentali, F., Akl, E. A., et al. American College of Chest Physicians. Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-based Clinical Practice Guidelines. Chest, 141(2 Suppl), e195S–226S.
  • Lloyd-Jones, D., Adams, R. J., Brown, T. M., Carnethon, M., Dai, S., Simone, G. D., et al. Wylie-Rosett, J. (2010). Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association. Circulation, 121(7), E46–E215.
  • Nicolaides, A. N., Fareed, J., Kakkar, A. K., Comerota, A. J., Goldhaber, S. Z., Hull, R., . . . Warwick, D. (2013). Prevention and treatment of venous thromboembolism--international consensus statement. International Angiology, 32(2), 111–260.
  • Office of the Surgeon General. (2008). The Surgeon General's Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism. Rockville, MD: National Heart, Lung, and Blood Institute (US). Available from: http://www.ncbi.nlm.nih.gov/books/NBK44178/.
  • Tagalakis, V., Patenaude, V., Kahn, S. R., & Suissa, S. (2013). Incidence of and mortality from venous thromboembolism in a real-world population: the Q-VTE Study Cohort. The American Journal of Medicine, 126(9), 832.e13–21.
  • Wells, P., Forgie, M., & Roger, M. (2014). Treatment of Venous Thromboembolism. Journal of the American Medical Association, 311(7), 717–728.
  • Yusuf, H. R., Tsai, J., Atrash, H. K., Boulet, S., & Grosse, S. D. (2012). Venous thromboembolism in adult hospitalizations−United States, 2007-2009. Morbidity and Mortality Weekly Report, 61(22): 401–404.
  • Zicotti, G. (Ed.). (2014). New Oral Anticoagulants for Acute Venous Thromboembolism. Journal of the American Medical Association, 311(7), 731–732
WORLD THROMBOSIS DAY
Powered by Translations.com GlobalLink OneLink Software